Join DeepLife for a transformative event on 19 February 2026 at Future4Care in Paris, where we'll explore how AI is revealing the hidden potential of existing drugs and creating unprecedented opportunities for maximizing value in today's competitive pharmaceutical landscape.

This exclusive gathering will bring together industry leaders, investors, clinicians, patient advocates and researchers to explore new markets, undiscovered targets and innovative approaches to drug lifecycle management. In an era of increasing R&D costs and regulatory pressures, finding new opportunity for existing drug represents one of the most promising strategies to accelerate time-to-market while reducing development risks.

Why attend?

Discover the latest strategies to identify novel indications and design more effective treatments for patients
Learn from real-world case studies - including success stories in drug innovation and cross-sector collaboration, along with presentations of breakthrough scientific research
Meet thought leaders and decision makers from across the sector

The agenda

Download the full programme here

Speakers include

Event details

Date: 19 February 2026

Time: 13:00 - 19:00 (CET)

Location: Future4Care, Paris

Format: In-person event followed by networking cocktail reception

Registration: Free, limited seats available - early registration recommended

Bonus: REPO4EU National Dissemination Event

In the morning at the same venue, we will be joining forces with REPO4EU, the euro/global platform for drug repurposing to co-host their National Dissemination Event. This event will showcase France's latest advances in drug repurposing and highlight how existing therapies can be reimagined to address unmet medical needs through collaboration and innovation.

👉 Learn more about the REPO4EU event: https://luma.com/oh9hr838

Infinite Unlocking new value in existing therapies